Lax security at Glorietta 5, Ayala Center, Makati ignored by Glorietta 5 bldg. administrator?
On December 6, 2010, I witnessed lax security at an entrance to Glorietta 5 building at Ayala Center, Makati. On said date, the guard at said entrance didn’t inspect my waist bag and the boots I was wearing. Said boots were large enough to each contain a firearm. Neither were said bag or boots scanned with a metal detector. Also, a bomb sniffing animal was not used to smell said bag or boots. On said date, I submitted, to a person who was at what was identified as a concierge within said building, a written complaint regarding said lax security. Said person, who identified herself as “Crystal Joice Benetva” affixed her signature on said written complaint. Up to April 22, 2011, neither said Glorietta 5 building administrator or anyone from said Ayala Center has contacted me
regarding said lax security.


Attention! senior citizens
Manila Mayor Lim ignoring CSC NCR letter re
my complaints vs. violations of the Expanded Senior Citizens Act of 2003?
I have a copy of a letter identified as from Atty. Myrna V. Macatangay Director IV Civil Service Commission Quezon City and addressed to Alfredo S. Lim City Mayor Manila City Government Manila City and dated January 6, 2011. Said letter contains the words: “We refer for appropriate action the attached . . . open letter of M. Silva . . . relative to his complaint against private entities in Manila City fot . . . violation of the Expanded Senior Citizens Act of 2003. Up to April 22, 2011, said Manila Mayor Lim has not contacted me regarding my said complaint.



Warning to Makati senior citizens
Public service warning and evidence vs. a person, identified as “Cipriano M. Guarin "OIC, OSCA Makati", City Hall, Makati.
I received a letter, identified as from said person and dated 02 June 2010 and addressed to me. Said letter contained the following words: "Seemingly, during your presence thereat on on April 20, 2010, you may have stationed yourself opposite one cash registry located at the left side of the counter and failed to detect the sign." Said words have no place in an objective statement of facts. I consider said words as an indication of said person’s bias towards KFC. "Except possibly for the provision of an express lane or giving priority to senior citizens, barbers shops are not (yet) covered by any other provisions of the Senior Citizens Act, therefore not required to display such notice or sign." What is the basis, if any, for said allegation by said Makati OSCA employee? Regarding the Bruno's store in Makati, said letter contained the following: ". . . when it was wiped clean, as witnessed by Ms. Luno and others present, there was no visible sign of any injury, not even a scratch". Is said statement based on said Guarin’s personal knowledge of said incident? Said letter also contained the following allegation regarding a Bruno's Barbers employee: "In order to avoid further misunderstanding or discussion, Ms. Luna prudently offered to you the services for free . . ." Said Makati OSCA employee was not present during said incident. Said Luna didn't charge me for said services because I told her that if she charged me for said services, I would use said O.R. as evidence vs. said store.




Advisory vs. Robinsons Department Store at Robinsons Place Ermita.
On April 27, 2011, said store issued to me sales invoice for Puritan brand products. Said invoice does not bear visible indication that I had 7 seven days withindication that I had 7 seven days within which I could exchange said products.
in which I could exchange said products.


Advisory vs. Senator Miriam Defensor Santiago:
Based on evidence, my registered letter,No. 10-26-8 addressed to said senator regarding the Department of Trade and Industry, was received on November 25, 2010, by said senator's agent. Up to April 26, 2011, said senator has not provided me with acknowledgement that
she received said letter.

Cosmetic Labeling & Label Claims
http://www.fda.gov/Cosmetics/CosmeticLabelingLabelClaims/default.htm

Overview
April 25, 2006
The following information is a brief introduction to labeling requirements. For a more thorough explanation of cosmetic labeling regulations, refer to FDA's Cosmetic Labeling Manual and the regulations themselves (21 CFR parts 701 and 740). Firms also may wish to discuss their labeling needs with a consultant.
Proper labeling is an important aspect of putting a cosmetic product on the market. FDA regulates cosmetic labeling under the authority of both the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA). These laws and their related regulations are intended to protect consumers from health hazards and deceptive practices and to help consumers make informed decisions regarding product purchase.
It is illegal to introduce a misbranded cosmetic into interstate commerce, and such products are subject to regulatory action. Some of the ways a cosmetic can become misbranded are:
its labeling is false or misleading,
its label fails to provide required information,
its required label information is not properly displayed, and
its labeling violates requirements of the Poison Prevention Packaging Act of 1970 [FD&C Act, sec. 602; 21 U.S.C. 362].
Does FDA pre-approve cosmetic product labeling?
No. FDA does not have the resources or authority under the law for pre-market approval of cosmetic product labeling. It is the manufacturer's and/or distributor's responsibility to ensure that products are labeled properly. Failure to comply with labeling requirements may result in a misbranded product.
Some labeling terms you should know
Before proceeding with a discussion of labeling requirements, it is helpful to know what some labeling terms mean:
Labeling. This term refers to all labels and other written, printed, or graphic matter on or accompanying a product [FD&C Act, sec. 201(m); 21 U.S.C. 321(m)].
Principal Display Panel (PDP). This is the part of the label most likely displayed or examined under customary conditions of display for sale [21 CFR 701.10].
Information Panel. Generally, this term refers to a panel other than the PDP that can accommodate label information where the consumer is likely to see it. Since the information must be prominent and conspicuous [21 CFR 701.2(a)(2)], the bottom of the package is generally not acceptable for placement of required information, such as the cosmetic ingredient declaration.
Is it permitted to label cosmetics "FDA Approved"?
No. As part of the prohibition against false or misleading information, no cosmetic may be labeled or advertised with statements suggesting that FDA has approved the product. This applies even if the establishment is registered or the product is on file with FDA's Voluntary Cosmetic Registration Program (VCRP) (see 21 CFR 710.8 and 720.9, which prohibit the use of participation in the VCRP to suggest official approval). False or misleading statements on labeling make a cosmetic misbranded [FD&C Act, sec. 602; 21 U.S.C. 362].
What about therapeutic claims?
Be aware that promoting a product with claims that it treats or prevents disease or otherwise affects the structure or any function of the body may cause the product to be considered a drug. FDA has an Import Alert in effect for cosmetics labeled with drug claims. For more information on drug claims, refer to Is It a Drug, a Cosmetic, or Both? (Or Is It Soap?).
How should products be labeled if they are both drugs and cosmetics?
If a product is an over-the-counter (OTC) drug as well as a cosmetic, its labeling must comply with the regulations for both OTC drug and cosmetic ingredient labeling [21 CFR 701.3(d)]. The drug ingredients must appear according to the OTC drug labeling requirements [21 CFR 201.66(c)(2) and (d)] and the cosmetic ingredients must appear separately, in order of decreasing predominance [21 CFR 201.66(c)(8) and (d)]. Contact the Center for Drug Evaluation and Research (CDER) for further information on drug labeling.
What languages are acceptable?
All labeling information that is required by law or regulation must be in English. The only exception to this rule is for products distributed solely in a U.S. territory where a different language is predominant, such as Puerto Rico. If the label or labeling contains any representation in a foreign language, all label information required under the FD&C Act must also appear in that language [21 CFR 701.2(b)].
What labeling information is required?
The following information must appear on the principal display panel:
An identity statement, indicating the nature and use of the product, by means of either the common or usual name, a descriptive name, a fanciful name understood by the public, or an illustration [21 CFR 701.11].
An accurate statement of the net quantity of contents, in terms of weight, measure, numerical count or a combination of numerical count and weight or measure [21 CFR 701.13].
The following information must appear on an information panel:
Name and place of business. This may be the manufacturer, packer, or distributor. [21 CFR 701.12].
Distributor statement. If the name and address are not those of the manufacturer, the label must say "Manufactured for..." or "Distributed by..." [21 CFR 701.12].
Material facts. Failure to reveal material facts is one form of misleading labeling and therefore makes a product misbranded [21 CFR 1.21]. An example is directions for safe use, if a product could be unsafe if used incorrectly.
Warning and caution statements. These must be prominent and conspicuous. The FD&C Act and related regulations specify warning and caution statements related to specific products [21 CFR part 700]. In addition, cosmetics that may be hazardous to consumers must bear appropriate label warnings [21 CFR 740.1]. An example of such hazardous products is flammable cosmetics.
Ingredients. If the product is sold on a retail basis to consumers, even it it is labeled "For professional use only" or words to that effect, the ingredients must appear on an information panel, in descending order of predominance. [21 CFR 701.3]. Remember, if the product is also a drug, its labeling must comply with the regulations for both OTC drug and cosmetic ingredient labeling, as stated above.
-
-
-
Page Last Updated: 12/31/2009

__________________________________________________________________________________________
web sites with free, useful information:

http://www.fueleconomy.gov/
fueleconomy gov web site
The official U.S. government source for fuel economy information



Information for Consumers (Drugs)
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/default.htm



Pesticides
http://www.niehs.nih.gov/health/topics/agents/pesticides/index.cfm



http://www.painfoundation.org/



U.S. FDA Buying & Using Medicine Safely
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/default.htm



Information for Consumers: Questions & Answers
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/default.htm
Questions and Answers for the public: Warning not to use Arrow Brand Medicated Oil & Embrocation, Aceite Medicinal La Flecha, or ?????
Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products
Compounded Menopausal Hormone Therapy Questions and Answers
Aspirin: Questions and Answers
Transition from CFC Propelled Albuterol Inhalers to HFA Propelled Albuterol Inhalers: Questions and Answers
Questions and Answers - Diabetes and Hyperglycemia in Patients Receiving Protease Inhibitors
Questions and Answers: Celebrex Labeling Change - Warfarin Interaction
Questions and Answers for Withdrawal of Duract
Questions and Answers on Importing Beef or Pork Insulin for Personal Use


Page Last Updated: 05/27/2010